baber/WOPTO huggingface dataset:
Patent PT-1838107-E (PT)
Title: Adaptive filtering based upon boundary strength
Inventor: LEI SHAWMIN
IPC: H04N11/04
Filed: 2002-09-11
Abstract: Adjacent regions are identified in an image. Coding parameters for the adjacent regions are identified. Selective filtering is performed at the region between the identified adjacent regions based on the identified coding parameters.
Patent PT-1851135-E (PT)
Title: Device for delivering fluids, especially pressurised medicating fluids
Inventor: BERTAUD OLIVIER
IPC: B65D83/00
Filed: 2006-02-14
Abstract: The invention relates to a device of the type adapted to deliver fluids, notably medicaments, under pressure. The device comprises a container 1 of variable volume in the form or shape of a pouch or flexible receptacle of generally cylindrical shape with longitudinal pleats 2 containing the fluid under pressure to be delivered and equipped with an actuator C permitting to open a valve 15 a , 15 b to enable the delivery of said fluid, the whole being located inside a container 4 capable of resisting to an elevated internal pressure, the internal volume of the latter container comprised between its wall and the container of variable volume being filled with a neutral gas under a pressure sufficient to exert on the container of variable volume a pneumatic constraint sufficient to permit the delivery of the therein contained fluid when the above-said valve permitting said delivery is operated by the aforementioned actuator C.
Patent PT-2221291-E (PT)
Title: Cyclohexenone compounds from antrodia camphorata and pharmaceutical compositions thereof useful for treating autoimmune diseases
Inventor: LIU SHENG-YUNG
IPC: A61K31/12
Filed: 2008-01-31
Abstract: The present invention relates to a compound of  Antrodia camphorata  used to treat autoimmune diseases, in particular to an extract, 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone, isolated from  Antrodia camphorata,  and its use in alleviating symptoms of autoimmune diseases such as systemic lupus erythematosus (SLE). The cyclohexenone compound according to the present invention helps to decrease proteinuria levels and antinuclear antibody titers in SLE mammals in order to alleviate kidney inflammation and disease, as well as the self-damage caused by antinuclear antibodies. The purpose for prevention and treatment of autoimmune diseases and kidney diseases by the natural, side-effect free substance can then be accomplished.
Patent PT-2146951-E (PT)
Title: Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
Inventor: BIADATTI-PORTAL THIBAUD
IPC: A61P17/00
Filed: 2008-04-24
Abstract: The invention relates to compounds corresponding to general formula (I) below: to the compositions containing same, to methods for the preparation thereof and to the use thereof in pharmaceutical compositions for use in human or veterinary medicine, or else in cosmetic compositions.
Patent PT-2358717-E (PT)
Title: Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
Inventor: WEBER ANN E
IPC: A61K31/4162
Filed: 2009-11-11
Abstract: The present invention is directed to a combination comprising a compound of structural formula I or a pharmaceutically acceptable salt thereof and an inhibitor of glucose uptake; wherein the variables are as defined in the specification. Compouds (I) are inhibtors of the enzyme dipeptidyl peptidase IV (dpp4-inhibitors) and may be used in the reatment of diabetes.
Patent PT-2366415-E (PT)
Title: Injection device
Inventor: HOGWOOD JONATHAN
IPC: A61M5/20
Filed: 2006-03-21
Abstract: An injection device is provided which includes a syringe having a discharge nozzle. The syringe is movable between a retracted position in which the discharge nozzle is contained within the housing and an extended position in which the discharge nozzle extends from the housing. A trigger is activatable to allow the contents of the syringe to be discharged through the discharge nozzle. There is also a releasable locking mechanism which, when engaged, prevents the trigger from moving into an active position. The trigger includes a first portion having a cut-out which extends from a first end of the trigger in a direction substantially parallel to the first axis. The releasable locking mechanism includes a protrusion along a second axis for communicating with the first portion of the trigger when the releasable locking mechanism is engaged and for communicating with the cut-out when the releasable locking mechanism is disengaged. Such an injection device provides improved protection against accidental activation of the trigger.
Patent PT-694014-E (PT)
Inventor: OLIFF JAMES R
IPC: B65D21/02
Filed: 1994-04-19
Abstract: PCT No. PCT/US94/04266 Sec. 371 Date Mar. 20, 1996 Sec. 102(e) Date Mar. 20, 1996 PCT Filed Apr. 19, 1994 PCT Pub. No. WO94/24014 PCT Pub. Date Oct. 27, 1994A package includes a plurality of cylindrical beverage cans (10) arranged into at least two tiers with a carton disposed around the cans. A paperboard divider panel (30) is disposed between and in contact with the cans of adjacent tiers. The divider panel includes a plurality of apertures (32), each of the apertures having a generally circular edge concentric with the cylindrical axis of upper and lower cans and having a diameter (D4) smaller than the base of the upper can. The divider panel further includes a substantially circular embossment (38) concentric with each of the apertures, the embossment having an outer diameter generally equal to the diameter of the top flange of the lower can.
Patent PT-704573-E (PT)
Inventor: KRUSS HEINRICH
IPC: E01C5/00
Filed: 1995-09-23
Abstract: The ground (2) is paved with water-permeable plaster blocks (13), these being placed on a bed (9,10,12) laid on the ground and of sand, plaster mixture and similar fine granular material and of constant thickness. Seams are formed between adjacent blocks and to a predetermined pattern. The ground slopes to one or more sides, acid-proof and pressure-resistant sheet material (7) being laid on it. At the bottom end (4) of the sheet is a drain pipe (6) at right angles to the slope, and which discharges into a collecting sump (5) contained in the ground. Between the fine sand (9) laid on the ground and the mixture (12) immediately below the blocks there can be a layer of glass ash (10) containing heater pipes (11). The gradient of the slope can be up to 3 percent.
Patent PT-954723-E (PT)
Inventor: WILLIAMS ALFRED T
IPC: E04B2/08
Filed: 1996-09-20
Abstract: A refractory brick and system of bricks for constructing flue walls of a ring furnace. The brick and the bricks of the system have opposed sides and upper and lower surfaces when disposed in a vertical wall structure, with one of the surfaces having at least one crosswise groove while the other surface has a corresponding crosswise tongue for seating in the groove of an adjacent brick, the tongues and grooves terminating short of the ends or sides of the brick when the bricks are disposed in a vertical wall structure. The crosswise tongues and grooves have rounded configurations sized to mate with bricks having the same tongue and groove configurations when a plurality of such bricks are stacked one upon the other in constructing a vertical wall.
Patent PT-798299-E (PT)
Inventor: PEDAIN JOSEF
IPC: C07D273/04
Filed: 1997-03-13
Abstract: Isocyanate trimers (or mixtures) (I) based on aliphatic,cycloaliphatic, aromatic or araliphatic mono- or poly-isocyanates (II) with a NCO content of less than 70%, optionally with other substituents in the organic groups, such as carbonyl or carboxyl groups or hetero atoms (or groups thereof) (halogen, O, S, N, P, Si, Sn, B), comprising mixtures of isocyanurate and imino- oxadiazinedione structures (formula A and B respectively) in the range from 70 mole% A plus 30 mole% B to 100 mole% B, with a mole ratio of trimer (A + B) to uretedione of more than 4:1 and with a content of uretonimines of less than 10 mole%. Also claimed are (i) mixtures of (I) with other isocyanate derivatives, e.g. urethane-("prepolymer")-, allophanate-, urea-, biuret-, uretedione- ("dimer") and/or oxadiazinetrione types, optionally substituted with NCO, CO or COOH groups or hetero units as above; and (ii) a process for the production of (I) by catalytic trimerisation of (II) with a NCO content of less than 75%, optionally substituted etc. as above.
Patent PT-816295-E (PT)
Inventor: SCOTT GARRETT L
IPC: C03B5/26
Filed: 1997-06-27
Abstract: A glass delivery system including a first forehearth (30) having an orifice, a second forehearth (34) having an orifice, a bottom pan assembly (32) adapted to be positioned underneath the orifice of the first forehearth (30), and a glass delivery tube (36) having an upper end adapted to be positioned underneath the orifice of the second forehearth (34) and a lower end adapted to deliver glass to the bottom pan assembly (32). The orifice is adapted to combine the glass from the two forehearths and, deliver cased glass to provide an interior glass from said first forehearth and an external layer of glass from said second forehearth. Provision is made for moving the glass delivery tube (36) horizontally, vertically and in azimuth relative to the second forehearth (34) and for moving the bottom assembly relative to the first forehearth. The glass delivery system includes a first carriage system (38) that supports the delivery tube assembly for movement horizontal, vertical and azimuth directions and a second carriage system (40) on which the bottom pan assembly (32) is mounted with respect to the first forehearth for moving the bottom pan assembly for horizontal movement relative to the first forehearth. <IMAGE>
Patent PT-918545-E (PT)
Inventor: BAGSHAWE KENNETH DAWSON
IPC: A61K47/48
Filed: 1997-11-28
Abstract: A three component therapeutic system comprising (i) a first compound, (ii) a catalytic macromolecule which does not specifically bind to a tumour antigen but which is capable, following administration to the vascular compartment of a mammal, of being taken up by a tumour in the mammal and is capable of converting the first compound into a second compound, and (iii) an inhibitor which, following administration to the said vascular compartment, reduces the level of the said catalytic conversion activity in the vascular compartment.
Patent PT-963904-E (PT)
Inventor: ALBA ADELARDO LOPEZ
IPC: B62D65/00
Filed: 1998-06-10
Abstract: Transport system with suspended load and lifting and lowering devices on board; characterised as it consists of: an elevated guide rail (1) which is totally horizontal, a motorised carriage (2) which moves longitudinally along a guide rail (1), a system to suspend the load (7) from the carriage (1) and a system to adjust the height of the load (7) at different stretches of the run; the system is controlled by a programmable robot. <IMAGE>
Patent PT-993394-E (PT)
Inventor: PFAFFELHUBER KLAUS
IPC: G10K11/172
Filed: 1998-06-08
Abstract: The aim of the invention is to simplify an underbody cowling so that it is easier to produce, without affecting the technical function of said cowling. To this end, the cowling (1) in the motor area of especially vehicles is transfer and/or injection moulded with the sealing lip (2) which serves to seal the vehicle body or similar, in the same material.
Patent PT-1018756-E (PT)
Inventor: RICAUD JEAN-FRANCOIS
IPC: H02B5/02
Filed: 1999-12-07
Abstract: The device incorporates its own transformer to provide a local low tension supply.  The electrical cut-out comprises a box (100) housing the cut-out mechanism, the box being made of metal and accommodating a voltage transformer (200). The metal box does not have right angle corners, but has cut off corners, giving rise to an octagonal horizontal section. The transformer within the box is a step-down transformer, changing from 20,000 volts to a low tension. This low tension is then used to operate an electronic cut-out management system. The line conductors (300) enter the box through insulating sleeves (360) made of a silicon material, with projecting fins (362). The cut-out box is sealed and may contain either a neutral gas, or an arc-extinguishing gas.
Patent PT-1098912-E (PT)
Inventor: KRISHNAMURTI RAMESH
IPC: C08L61/34
Filed: 1999-07-30
Abstract: Disclosed is a method of inhibiting the formation of scale on reactor surfaces in contact with a polymerizing vinyl monomer comprising contacting said monomer with a terpolymer which comprises the condensation reaction product of (A) an aromatic compound that contains the group where Q is OR or SR and R is hydrogen, alkyl from C1 to C15, or aryl, alkaryl, or aralkyl from C6 to C15: (B) about 0.1 to about 10 moles of a carbonyl compound per mole of said aromatic compound; and (C) about 0.1 to about 10 moles of a thiourea per mole of said aromatic compound.
Patent PT-1086223-E (PT)
Title: Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
Inventor: MITCHELL STEPHEN CHAPPELL
IPC: C07K14/705
Filed: 1999-06-01
Abstract: Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STRAP" (Serpentine TRansmembrane Antigens of the Prostate). Four particular human STRAPs are described and characterized herein. The human STRAPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STRAP family, STRAP-1, appears to be a type IIIa membrane protein expressed predominantly in prostate cells in normal human tissues.; Structurally, STRAP-1 is a 339 amino acid protein characterized by a molecular topology of six transmembrane domains and intracellular N- and C-termini, suggesting that it folds in a "serpentine" manner into three extracellular and two intracellular loops. STRAP-1 protein expression is maintained at high levels across various stages of prostate cancer. Moreover, STRAP-1 is highly over-expressed in certain other human cancers.
Patent SG-11088-G (SG)
Title: Bilateral fenestrated drape
IPC: A61B19/08
Filed: 1988-02-08
Abstract: A bilateral fenestrated drape folded in such a manner to eliminate the need for removable paper coverings over the fenestrations. The drape is fan folded in the longitudinal direction and then fan folded transversely to form two stacks of the folds with a bridging or central portion between the stacks. The bridging portion is folded to form flaps which are used to cover the fenestrations.
Patent IE-37581-L (IE)
Title: Piperazine derivatives.
IPC: C07D295/08
Filed: 1973-04-30
Abstract: 1382536 Piperazine derivatives SYNTHELABO 26 April 1973 [3 May 1972] 19850/73 Heading C2C The invention comprises piperazine derivatives of the formula in which A is -(CH 2 ) n -COOR where n is an integer from 1 to 6 and R is a straight or branched alkyl radical of 1 to 6 carbon atoms, or A is -CH 2 -(CH 2 ) n -R 1 in which n is as above and R 1 is CN or COOH, and their pharmaceutically acceptable acid addition salts and, where R 1 is COOH, their pharmaceutically acceptable salts with bases. The piperazine derivatives may be prepared by (a) reacting N-(m-trifluoromethylthiophenyl)-piperazine with a halogeno compound of the formula A-X in which X is chlorine, bromine or iodine and A is as above. The reaction may be carried out by heating the two starting materials together in an inert organic solvent in the presence of an acceptor for the hydrohalic acid liberated; (b) reacting a compound of formula with a compound of formula in which one of Y and Z is CH 2 -CH 2 -X and the other is hydrogen and A and X are as above. The reaction may be carried out in an inert organic solvent in the presence of an acceptor for the hydrohalic acid liberated; (c) and in which A is -CH 2 CH 2 CN or -CH 2 -CH 2 COOR reacting together N - (m - trifluoromethylthiophenyl)-piperazine and an acrylic compound of formula CH 2 =CH-T in which T is CN or COOR. The reaction may be carried out with or without a solvent and preferably in the presence of a condensation catalyst such as benzyltrimethylammonium hydroxide. A still further method of making the compounds in which A is CH 2 -(CH 2 ) n -CN comprises reacting a compound of formula with a metallic cyanide. The compound of formula above wherein X is chlorine, bromine or iodine and n is an integer of from 1 to 6 is also claimed per se and may be prepared by the reaction of a halogenation agent with an alcohol of the formula
[GB1382536A]
Patent IE-35727-L (IE)
Title: Benzodiazepines.
IPC: C07D243/12
Filed: 1970-06-10
Abstract: 1317475 1 H - 2,3,4,5 - Tetrahydro - 1,5- benzodiazepin - 4 - ones BOEHRINGER INGELHEIM GmbH 10 June 1970 [11 June 1969 13 Feb 1970 23 April 1970] 28197/70 Heading C2C Novel 1H - 2,3,4,5 - tetrahydro - 1,5 - benzodiazepin-4-ones of the general formula wherein R 1 is a hydrogen atom or a straight or branched chain C 1-6 alkyl group, an unsaturated aliphatic C 2-6 hydrocarbon group, a C 2-3 alkyl group substituted by a hydroxy group in the terminal position, or a C 4-7 cycloalkylmethyl or formyl group, R 2 is an α-pyridyl group, or a phenyl group optionally substituted in the oposition thereof by a halogen atom or a nitro or trifluoromethyl group and R 3 is a hydrogen or halogen atom or a hydroxy, trifluoromethyl, nitro or cyano group, and, except when R 1 is a formyl group and R 2 is other than an α-pyridyl group, physiologically acceptable acid addition salts thereof are prepared (a) when R 1 is other than a formyl group, by reaction of a 1H-2,3,4,5- tetrahydro - 1,5 - benzodiazepin - 4 - one of the general formula wherein R 4 is as R 1 with the exception of a formyl group, with an aryl or heteroaryl halide of the general formula R 2 X, wherein X is a halogen atom; (b) when R 1 is other than a formyl group, by cyclization of an N-(2-anilinophenyl)-#-alanine of the general formula (c) when R 1 is other than a formyl group, by cyclization of an N-acyl-o-phenylenediamine of the general formula wherein Y is a vinyl or 2-haloethyl group; (d) when R 1 is other than a hydrogen atom, by reaction of a lH-2,3,4,5-tetrahydro-1,5-benzodiazepin-4-one of the general formula with a compound of the general formula R 5 Y, wherein R 5 is as R 1 with the exception of a hydrogen atom and Y is an atom or group readily removable as an anion; (e) when R 1 is a 2-hydroxyethyl group, by reaction of a 1H-2,3,4,5 - tetrahydro - 1,5 - benzodiazepin-4- one of the sixth general formula above with ethylene oxide, and (f) when R 1 is a formyl group, by reaction of a 1H-2,3,4,5-tetrahydro- 1,5 - benzodiazepin - 4 - one of the sixth general formula above with formic acid; followed optionally, where appropriate, by salification of the product. Pharmaceutical compositions having tranquillizing activity comprise, as active ingredient, at least one lH-2,3,4,5-tetrahydro-1,5-benzodiazepin-4-one of the first general formula above or physiologically acceptable acid addition salt thereof, in association with a pharmaceutical carrier or excipient, and may be administered orally, parenterally or rectally.
[GB1317475A]
Patent IE-830876-L (IE)
Title: Screening apparatus
IPC: B07B1/00
Filed: 1983-04-18
Abstract: A screening apparatus includes a conveyor (10) pivotally mounted at its rear end on a wheeled chassis (2). The conveyor (10) includes a rear section (12) and a forward section (14) telescopically connected to the rear section, (12). An endless belt (16) is guided and powered by spaced rollers (18) mounted on the conveyor rear and forward sections (12) and (14). The conveyor (10) is moved between its operational and transporting positions by a jacking cylinder (20). A screen device (32) is pivotally coupled to the output stage of the forward section (14), and is controlled by a ram. A hopper (8) for receiving the material to be separated is mounted on the chassis (2). To convert the apparatus from its operational position to its transporting position, the jacking cylinder (20) lowers the conveyor (10), two sets of troughing rollers are removed from the forward section (14), and the ram is disconnected from the forward section (14). This forward section (14) is partially telescoped into the rear section (12), and the screen device (30) is pivoted clockwise and bolted to the rear section (12). <IMAGE>
[GB2119290A]
Patent IE-820907-L (IE)
Title: Enzyme product
IPC: C12P19/16
Filed: 1982-04-19
Abstract: A novel debranching enzyme product with properties in terms of thermostability and pH-optimum comparable to those of glucoamylase is produced by cultivating a strain belonging to the novel taxonomic group Bacillus acidopullulyticus. The novel debranching enzyme is used in conjunction with known saccharifying enzymes for the hydrolysis of starch.
Patent IE-780949-L (IE)
Title: Liquid hard surface cleaners
IPC: C11D1/66
Filed: 1978-05-09
Abstract: A liquid hard surface cleaner is disclosed that is impalpable, self-opacifying, enjoys low temperature stability and has satisfactory viscosity and detergency, these being achieved by a particular combination of ingredients and proportions; namely, the composition comprising, by weight, a water-soluble, synthetic, anionic, sulphated or sulphonated detergent salt containing an alkyl radical of 8 to 22 carbon atoms in the molecule, a water-soluble alkylene oxylated nonionic detergent, a water-soluble detergent builder salt and the balance water, the weight ratio of anionic detergent to nonionic detergent being from 0:5 to 6:1 and the weight ratio of builder salt to total detergent being in the range of 1:5 to 5:1.
Patent IE-790959-L (IE)
Title: Ion exchanger regeneration
IPC: C13B20/14
Filed: 1979-08-08
Abstract: Process of regeneration of a strongly acid exchanger of cations containing magnesium. 
The exchanger used is put in contact of a kieserite solution. 
[FR2427129A1]
Patent FI-844270-L (FI)
Inventor: CHURCHLAND MARK T
IPC: B27M1/08
Filed: 1984-10-31
Abstract: The present invention relates to a process of forming an extended elongate product from a plurality of strands by subjecting the strands to heat and pressure. The improvement of the present invention comprises a method for compressing the strands in a manner to reduce internal stresses imparted to the product during its subjection to pressure. The method includes the steps of: (a) transporting in a longitudinal direction the strands in a generally parallel and overlapping relationship through a compressing zone of a press assembly; (b) increasing the pressure on the strands as they pass from an inlet end to an outlet end of the compressing zone by gradually converging facing walls of the press assembly so that: (i) the strands being compressed move relative to one another through at least a portion of the compressing zone; and (ii) the strands being compressed lock up so that they no longer move relative to one another but rather only compress relative to one another at a point in the compressing zone where the radius of curvature in the longitudinal direction on either side of a central reference plane of the mat being compressed is at least about 30 feet to provide a low remembered internal stress.
Patent IE-821210-L (IE)
Title: Guanine derivatives
IPC: C07D/
Filed: 1982-05-20
Abstract: The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine and the pharmaceutically acceptable salts thereof are useful as antiviral agents.
[US4355032A]
Patent IE-791512-L (IE)
Title: Excavating trenches
IPC: E02F5/02
Filed: 1979-08-08
Abstract: An apparatus for excavating a trench in ground comprises two blades (4) which are laterally spaced apart and which are arranged to form two slits in the ground as the apparatus moves over the ground (7). Two laterally spaced excavating elements (9), which are preferably rotatable discs resiliently biased towards each other, are arranged one behind each blade run in the cut of the preceding blade and are operable to grip spoil between the cuts and remove the spoil to form the trench.